Lipidor AB focuses on developing innovative drug delivery systems, particularly in the field of topical treatments. The company utilizes its proprietary technology, which enhances the absorption of active pharmaceutical ingredients through the skin. This technology is designed to improve the efficacy and safety of medications, allowing for more effective treatment options for patients with various conditions. Lipidor's approach aims to optimize the formulation of drugs, ensuring that they can penetrate the skin barrier effectively while minimizing potential side effects.

In addition to its drug delivery systems, Lipidor is also engaged in the development of a range of products targeting dermatological conditions. The company’s pipeline includes formulations that leverage its advanced technology to provide targeted therapy for skin diseases, thereby improving patient outcomes. By focusing on both the scientific and practical aspects of drug formulation, Lipidor AB is positioned to make significant contributions to the pharmaceutical industry, particularly in the realm of topical therapies.

Sweden

Lipidor AB is a Stockholm-based formulation research company. Its lipid based technology, AKVANO® represents an innovative dosage form consisting of water-free, sprayable liquid formulations in which selected lipids and the active ingredient are dissolved in a volatile solvent. The novel formulation technology offers unique product opportunities across dermatology, wound and skin care markets. The Company develops topical medical products for the treatment of diseases such as psoriasis, acne vulgaris, bacterial skin infections and atopic dermatitis by reformulation of proven pharmaceutical substances.

Lipidor AB

Company Details